Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study

NCT04754542 · clinicaltrials.gov ↗
COMPLETED
Status
76
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Colorado, Denver

Collaborators